Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pediatrix Medical (MD) Receivables - Other (2017 - 2024)

Historic Receivables - Other for Pediatrix Medical (MD) over the last 8 years, with Q4 2024 value amounting to $28.5 million.

  • Pediatrix Medical's Receivables - Other fell 1415.66% to $28.5 million in Q4 2024 from the same period last year, while for Dec 2024 it was $28.5 million, marking a year-over-year decrease of 1415.66%. This contributed to the annual value of $28.5 million for FY2024, which is 1415.66% down from last year.
  • Pediatrix Medical's Receivables - Other amounted to $28.5 million in Q4 2024, which was down 1415.66% from $33.2 million recorded in Q4 2023.
  • Over the past 5 years, Pediatrix Medical's Receivables - Other peaked at $61.4 million during Q4 2020, and registered a low of $28.5 million during Q4 2024.
  • Moreover, its 5-year median value for Receivables - Other was $54.7 million (2022), whereas its average is $47.2 million.
  • Its Receivables - Other has fluctuated over the past 5 years, first surged by 10604.03% in 2020, then plummeted by 3930.53% in 2023.
  • Pediatrix Medical's Receivables - Other (Quarter) stood at $61.4 million in 2020, then fell by 5.37% to $58.1 million in 2021, then dropped by 5.85% to $54.7 million in 2022, then tumbled by 39.31% to $33.2 million in 2023, then decreased by 14.16% to $28.5 million in 2024.
  • Its last three reported values are $28.5 million in Q4 2024, $33.2 million for Q4 2023, and $54.7 million during Q4 2022.